Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements and Hierarchy - Carrying Value of Financial Instruments (Details)

v3.22.2.2
Fair Value Measurements and Hierarchy - Carrying Value of Financial Instruments (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Fair Value Measurements and Hierarchy          
Financial Designation, Predecessor and Successor [Fixed List] Successor Predecessor Successor Predecessor  
Cash $ 34,357,237 $ 4,336,565 $ 34,357,237 $ 4,336,565 $ 140,477,586
Restricted Cash 1,003,307 $ 346,299 1,003,307 $ 346,299 356,286
Clinic Fees and Insurance Receivables, Net 1,049,253   1,049,253   1,090,104
Other Receivables 2,736,184   2,736,184   726,903
Accounts Payable and Accrued Expenses 24,072,391   24,072,391   17,730,683
Liability for warrants $ 7,996,432   $ 7,996,432   $ 11,382,826